Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team

Peptonic Medical

0,00 SEK

0,00 %

Mindre end 1K følgere

PMED

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
Sammenligne
0,00 %
+9,09 %
+50,00 %
0,00 %
-36,84 %
-45,45 %
-96,78 %
-99,70 %
-99,86 %

Peptonic Medical is a pharmaceutical company. Currently, the focus is on the treatment of female vaginal atrophy. The company offers a treatment free from oestrogen, where the products contain the oxytocin hormone. A large part of the projects is carried out in collaboration with other industry players. The main business is found on the Nordic market. The company is based in Bromma.

Læs mere
Markedsværdi
22,41 mio. SEK
Aktieomsætning
80,58 t SEK
Omsætning
26,89 mio.
EBIT %
-218,11 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
25.2
2026

Årsrapport '25

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelse28.11.2025, 14.00

PEPTONIC Medical AB: Peptonic Medical AB's reconstruction plan approved by the Uppsala District Court

Peptonic Medical
Selskabsmeddelelse27.11.2025, 11.45

PEPTONIC Medical AB: Peptonic Medical AB: Plan Hearing Held at Uppsala District Court

Peptonic Medical
Selskabsmeddelelse27.11.2025, 07.30

PEPTONIC Medical AB: Peptonic Medical AB Presents Current Sales Figures

Peptonic Medical

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse17.11.2025, 12.45

PEPTONIC Medical AB: Correction: Peptonic Medical AB (publ) - Corporate Restructuring Continues

Peptonic Medical
Selskabsmeddelelse17.11.2025, 12.00

PEPTONIC Medical AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction

Peptonic Medical
Selskabsmeddelelse30.10.2025, 06.30

PEPTONIC Medical AB: Peptonic Medical receives part of first order from Joylux worth USD 126,000

Peptonic Medical
Selskabsmeddelelse27.10.2025, 13.34

PEPTONIC Medical AB: Date for the Plan Meeting in the Corporate Reorganization of Peptonic Medical AB (publ) Announced

Peptonic Medical
Selskabsmeddelelse23.10.2025, 20.24

PEPTONIC Medical AB: Reconstruction Plan in Peptonic Medical AB (publ)'s Corporate Restructuring Published

Peptonic Medical
Selskabsmeddelelse14.10.2025, 05.36

PEPTONIC Medical AB: Peptonic Medical signs strategic distribution agreement with Joylux Inc. for the USA, Canada, Mexico, and the UK

Peptonic Medical
Selskabsmeddelelse19.9.2025, 09.30

PEPTONIC Medical AB: Peptonic Medical: Uppsala District Court approves extension of corporate reconstruction

Peptonic Medical
Selskabsmeddelelse10.9.2025, 17.45

PEPTONIC Medical AB: Peptonic Medical requests extension of corporate reconstruction and provides update on financial performance

Peptonic Medical
Selskabsmeddelelse26.8.2025, 06.00

PEPTONIC Medical AB: Peptonic Medical AB: Anna Linton resigns as CEO

Peptonic Medical
Selskabsmeddelelse26.6.2025, 10.05

PEPTONIC Medical AB: Bulletin from the annual general meeting in PEPTONIC medical AB

Peptonic Medical
Selskabsmeddelelse19.6.2025, 14.30

PEPTONIC Medical AB: PEPTONIC medical AB presents proposals for board members ahead of the annual general meeting on 26 June 2025

Peptonic Medical
Selskabsmeddelelse17.6.2025, 12.00

PEPTONIC Medical AB: Peptonic Medical's request for extension of company reconstruction approved by Uppsala District Court

Peptonic Medical
Selskabsmeddelelse8.6.2025, 19.50

PEPTONIC Medical AB: Peptonic Medical: Request for extension of company reconstruction and update on the reconstruction process

Peptonic Medical
Selskabsmeddelelse8.6.2025, 18.45

PEPTONIC Medical AB: Correction: Peptonic Medical's Annual Report 2024 published

Peptonic Medical
Selskabsmeddelelse5.6.2025, 19.20

PEPTONIC Medical AB: Peptonic Medical's Annual Report 2024 published

Peptonic Medical
Selskabsmeddelelse5.6.2025, 15.40

PEPTONIC Medical AB: Intends to submit a request for extension of ongoing corporate restructuring

Peptonic Medical
Selskabsmeddelelse23.5.2025, 12.00

PEPTONIC Medical AB: NOTICE TO THE ANNUAL GENERAL MEETING IN PEPTONIC MEDICAL AB

Peptonic Medical
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.